相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
T. Yokota et al.
BRITISH JOURNAL OF CANCER (2011)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
KRAS and BRAF: drug targets and predictive biomarkers
Efsevia Vakiani et al.
JOURNAL OF PATHOLOGY (2011)
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
Emma R. Cantwell-Dorris et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Stage III Colorectal Cancer: Molecular Disparity Between Primary Cancers and Lymph Node Metastases
Craig A. Messick et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome
Z. Saridaki et al.
BRITISH JOURNAL OF CANCER (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
J. Souglakos et al.
BRITISH JOURNAL OF CANCER (2009)
Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer
J. A. Sanchez et al.
BRITISH JOURNAL OF SURGERY (2009)
Divergent Oncogenic Changes Influence Survival Differences between Colon and Rectal Adenocarcinomas
Matthew F. Kalady et al.
DISEASES OF THE COLON & RECTUM (2009)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
David Z. Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
BRAF Mutation in Metastatic Colorectal Cancer.
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations
A. Preto et al.
JOURNAL OF PATHOLOGY (2008)
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma
Shuji Ogino et al.
VIRCHOWS ARCHIV (2007)
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
J. R. Jass
HISTOPATHOLOGY (2007)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
GR Deng et al.
CLINICAL CANCER RESEARCH (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
